We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$124B
AUM Growth
-$818M
(-0.66%)
Cap. Flow
-$3.27B
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
4,253
New
85
Increased
832
Reduced
2,978
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$588M |
| 2 |
CRH
CRH
|
+$47.1M |
| 3 |
Carvana
CVNA
|
+$34.4M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$33.9M |
| 5 |
Pinterest
PINS
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$326M |
| 2 |
Apple
AAPL
|
+$286M |
| 3 |
Microsoft
MSFT
|
+$251M |
| 4 |
MRSH
Marsh
MRSH
|
+$174M |
| 5 |
Amazon
AMZN
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Financials | 13.22% |
| 3 | Consumer Discretionary | 10.75% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Nabors Industries
NBR
$1.38B
| $2.39M | ﹤0.01% |
44,043
-2,539
| -5% | -$124K |
|
|
AGNT
1752
AGNT Inc
AGNT
$739M
| $2.38M | ﹤0.01% |
263,449
-45,479
| -15% | -$480K |
|
1753
Integra LifeSciences
IART
$1.43B
| $2.38M | ﹤0.01% |
191,923
-9,877
| -5% | -$131K |
|
1754
Astrana Health
ASTH
$1.99B
| $2.38M | ﹤0.01% |
95,894
-1,448
| -1% | -$38.5K |
|
1755
nLIGHT
LASR
$3B
| $2.37M | ﹤0.01% |
63,279
-10,123
| -14% | -$338K |
|
1756
Capitol Federal Financial
CFFN
$1.09B
| $2.37M | ﹤0.01% |
348,489
-20,535
| -6% | -$134K |
|
1757
Celldex Therapeutics
CLDX
$3.22B
| $2.37M | ﹤0.01% |
87,264
-15,893
| -15% | -$419K |
|
1758
Disc Medicine
IRON
$3.01B
| $2.37M | ﹤0.01% |
29,833
-4,657
| -14% | -$394K |
|
1759
Matthews International
MATW
$726M
| $2.36M | ﹤0.01% |
90,541
-5,080
| -5% | -$125K |
|
1760
Scholastic
SCHL
$784M
| $2.36M | ﹤0.01% |
79,811
-3,939
| -5% | -$113K |
|
1761
Globant
GLOB
$1.63B
| $2.36M | ﹤0.01% |
36,154
+818
| +2% | +$51.4K |
|
1762
TriNet
TNET
$3.16B
| $2.36M | ﹤0.01% |
39,930
-6,673
| -14% | -$396K |
|
1763
PDF Solutions
PDFS
$2.12B
| $2.35M | ﹤0.01% |
82,477
-4,441
| -5% | -$123K |
|
1764
Turning Point Brands
TPB
$1.75B
| $2.35M | ﹤0.01% |
21,669
-3,455
| -14% | -$338K |
|
1765
nCino
NCNO
$2.26B
| $2.35M | ﹤0.01% |
91,539
-947
| -1% | -$24K |
|
1766
Ultragenyx Pharmaceutical
RARE
$2.57B
| $2.34M | ﹤0.01% |
101,826
-3,905
| -4% | -$128K |
|
|
LINE
1767
Lineage Inc
LINE
$9.62B
| $2.34M | ﹤0.01% |
66,856
+3,741
| +6% | +$138K |
|
1768
10x Genomics
TXG
$7.41B
| $2.34M | ﹤0.01% |
143,440
-19,341
| -12% | -$292K |
|
1769
CNA Financial
CNA
$13.9B
| $2.34M | ﹤0.01% |
48,942
-39,602
| -45% | -$1.83M |
|
1770
F&G Annuities & Life
FG
$3.61B
| $2.34M | ﹤0.01% |
75,704
+39,258
| +108% | +$1.23M |
|
1771
Quantum Computing Inc
QUBT
$2.03B
| $2.33M | ﹤0.01% |
227,345
+35,709
| +19% | +$508K |
|
1772
Sprinklr
CXM
$1.62B
| $2.33M | ﹤0.01% |
299,764
-26,012
| -8% | -$198K |
|
1773
RingCentral
RNG
$5.41B
| $2.33M | ﹤0.01% |
80,556
-2,524
| -3% | -$71.9K |
|
1774
Grupo Aeroportuario del Pacifico
PAC
$12.3B
| $2.32M | ﹤0.01% |
8,813
-605
| -6% | -$141K |
|
|
DX
1775
Dynex Capital
DX
$3.25B
| $2.32M | ﹤0.01% |
165,414
-12,180
| -7% | -$164K |
|
Similar funds
RhumbLine Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, RhumbLine Advisers held 4,253 positions worth $124B, down 0.66% from $125B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.6%. RhumbLine Advisers opened 85 new positions and exited 67, leaving the 4,253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2025 buy was Qnity Electronics Inc: 399,119 shares worth $32.6M.
- RhumbLine Advisers added most to iShares Russell 3000 ETF in Q4 2025, an estimated $588M increase.
- RhumbLine Advisers's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $326M.
- RhumbLine Advisers fully exited Kellanova in Q4 2025, selling an estimated $52.6M.
- RhumbLine Advisers's ten largest holdings make up 33% of its $124B portfolio in Q4 2025.
- RhumbLine Advisers opened 85 new positions and closed 67 in Q4 2025.
- RhumbLine Advisers's portfolio value fell 0.66% quarter-over-quarter to $124B.
Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.